198 related articles for article (PubMed ID: 35306580)
1. Muscle-invasive bladder cancer: pretreatment prediction of response to neoadjuvant chemotherapy with diffusion-weighted MR imaging.
Zhang X; Wang Y; Zhang J; Xu X; Zhang L; Zhang M; Xie L; Shou J; Chen Y
Abdom Radiol (NY); 2022 Jun; 47(6):2148-2157. PubMed ID: 35306580
[TBL] [Abstract][Full Text] [Related]
2. Combining volumetric apparent diffusion coefficient histogram analysis with vesical imaging reporting and data system to predict the muscle invasion of bladder cancer.
Li S; Liang P; Wang Y; Feng C; Shen Y; Hu X; Hu D; Meng X; Li Z
Abdom Radiol (NY); 2021 Sep; 46(9):4301-4310. PubMed ID: 33909091
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of contrast-enhanced dynamic and diffusion-weighted MR imaging in the assessment of tumor response to neoadjuvant therapy in muscle-invasive bladder cancer.
Ahmed SA; Taher MGA; Ali WA; Ebrahem MAES
Abdom Radiol (NY); 2021 Jun; 46(6):2712-2721. PubMed ID: 33547919
[TBL] [Abstract][Full Text] [Related]
4. Quantitative multiparametric MRI as a promising tool for the assessment of early response to neoadjuvant chemotherapy in bladder cancer.
Yang X; Yuan B; Zhang Y; Zhuang J; Cai L; Wu Q; Cao Q; Li P; Lu Q; Sun X
Eur J Radiol; 2022 Dec; 157():110587. PubMed ID: 36345088
[TBL] [Abstract][Full Text] [Related]
5. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Park SH; Moon WK; Cho N; Song IC; Chang JM; Park IA; Han W; Noh DY
Radiology; 2010 Oct; 257(1):56-63. PubMed ID: 20851939
[TBL] [Abstract][Full Text] [Related]
7. Assessing Bladder Radiotherapy Response With Quantitative Diffusion-Weighted Magnetic Resonance Imaging Analysis.
Hafeez S; Koh M; Jones K; El Ghzal A; D'Arcy J; Kumar P; Khoo V; Lalondrelle S; McDonald F; Thompson A; Scurr E; Sohaib A; Huddart R
Clin Oncol (R Coll Radiol); 2022 Oct; 34(10):630-641. PubMed ID: 35534398
[TBL] [Abstract][Full Text] [Related]
8. Histogram analysis of apparent diffusion coefficients after neoadjuvant chemotherapy in breast cancer.
Kim YJ; Kim SH; Lee AW; Jin MS; Kang BJ; Song BJ
Jpn J Radiol; 2016 Oct; 34(10):657-666. PubMed ID: 27517370
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
10. Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion.
Tsuchiya N; Doai M; Usuda K; Uramoto H; Tonami H
PLoS One; 2017; 12(2):e0172433. PubMed ID: 28207858
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
Musall BC; Adrada BE; Candelaria RP; Mohamed RMM; Abdelhafez AH; Son JB; Sun J; Santiago L; Whitman GJ; Moseley TW; Scoggins ME; Mahmoud HS; White JB; Hwang KP; Elshafeey NA; Boge M; Zhang S; Litton JK; Valero V; Tripathy D; Thompson AM; Yam C; Wei P; Moulder SL; Pagel MD; Yang WT; Ma J; Rauch GM
J Magn Reson Imaging; 2022 Dec; 56(6):1901-1909. PubMed ID: 35499264
[TBL] [Abstract][Full Text] [Related]
13. Intravoxel incoherent motion diffusion-weighted MRI for predicting response to neoadjuvant chemotherapy in breast cancer.
Kim Y; Kim SH; Lee HW; Song BJ; Kang BJ; Lee A; Nam Y
Magn Reson Imaging; 2018 May; 48():27-33. PubMed ID: 29278762
[TBL] [Abstract][Full Text] [Related]
14. Apparent diffusion coefficient histogram analysis for predicting neoadjuvant chemoradiotherapy response in patients with rectal cancer.
Babatürk A; Erden A; Geçim İE
Diagn Interv Radiol; 2022 Sep; 28(5):403-409. PubMed ID: 35997474
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced and diffusion-weighted MR imaging in early prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Li J; Yan LL; Zhang HK; Wang Y; Xu SN; Li HL; Qu JR
Abdom Radiol (NY); 2022 Oct; 47(10):3394-3405. PubMed ID: 35916943
[TBL] [Abstract][Full Text] [Related]
16. Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases.
Liang HY; Huang YQ; Yang ZX; Ying-Ding ; Zeng MS; Rao SX
Eur Radiol; 2016 Jul; 26(7):2009-18. PubMed ID: 26494642
[TBL] [Abstract][Full Text] [Related]
17. Whole lesion histogram analysis of apparent diffusion coefficient predicts therapy response in locally advanced rectal cancer.
Jiménez de Los Santos ME; Reyes-Pérez JA; Domínguez Osorio V; Villaseñor-Navarro Y; Moreno-Astudillo L; Vela-Sarmiento I; Sollozo-Dupont I
World J Gastroenterol; 2022 Jun; 28(23):2609-2624. PubMed ID: 35949349
[TBL] [Abstract][Full Text] [Related]
18. Can whole-tumor apparent diffusion coefficient histogram analysis be helpful to evaluate breast phyllode tumor grades?
Guo Y; Tang WJ; Kong QC; Liang YY; Han XR; Zheng BJ; Sun L; Wei XH; Jin Z; Liu CL
Eur J Radiol; 2019 May; 114():25-31. PubMed ID: 31005172
[TBL] [Abstract][Full Text] [Related]
19. Preoperative histogram analysis of intravoxel incoherent motion (IVIM) for predicting microvascular invasion in patients with single hepatocellular carcinoma.
Li H; Zhang J; Zheng Z; Guo Y; Chen M; Xie C; Zhang Z; Mei Y; Feng Y; Xu Y
Eur J Radiol; 2018 Aug; 105():65-71. PubMed ID: 30017300
[TBL] [Abstract][Full Text] [Related]
20. Development of a MRI-Based Radiomics Nomogram for Prediction of Response of Patients With Muscle-Invasive Bladder Cancer to Neoadjuvant Chemotherapy.
Zhang X; Wang Y; Zhang J; Zhang L; Wang S; Chen Y
Front Oncol; 2022; 12():878499. PubMed ID: 35646654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
